Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June - July - August - September - Oktober - November - December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
- 2020
June 2020 - 62 products
IP
Treprostinil OrPha 1
mg/ml
10 ml
PR
PR
k.A.
Infusion solution: Treprostinilum 1 mg/ml
OrPha Swiss GmbH
B
FB
G
IP
Treprostinil OrPha 2.5
mg/ml
10 ml
PR
PR
k.A.
Infusion solution: Treprostinilum 2.5 mg/ml
OrPha Swiss GmbH
B
FB
G
IP
Treprostinil OrPha 5
mg/ml
10 ml
PR
PR
k.A.
Infusion solution: Treprostinilum 5 mg/ml
OrPha Swiss GmbH
B
FB
G
IP
Treprostinil OrPha 10
mg/ml
10 ml
PR
PR
k.A.
Infusion solution: Treprostinilum 10 mg/ml
OrPha Swiss GmbH
B
FB
G
Inhixa 2000 IE (20 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 20 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 2000 IE (20 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 20 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 4000 IE (40 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 40 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 4000 IE (40 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 40 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 4000 IE (40 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 40 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 6000 IE (60 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 60 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 8000 IE (80 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 80 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 10000 IE (100 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 100 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 12000 IE (120 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 120 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 15000 IE (150 mg)
10
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 150 mg
Mylan Pharma GmbH
B
FB
G
Inhixa Multi 30000 IE
(300 mg)
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 300 mg
Mylan Pharma GmbH
B
FB
G
IP
V/S
Berinert SC 2000 IU
/ 0 UI
PR
PR
k.A.
Lyophilisate and solvent: C1-inhibitor Humanus 2000 UI
CSL Behring AG
B
FB
G
IP
NUBEQA 300 mg
112
PR
PR
k.A.
Coated tablets: Darolutamidum 300 mg
Bayer (Schweiz) AG
B
FB
G
Vividrin 0.5 mg/ml
6 ml
PR
PR
k.A.
Eye drops: Azelastini Hydrochloridum
Bausch & Lomb Swiss AG
B
FB
G
Inhixa 2000 IE (20 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 20 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 6000 IE (60 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 60 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 6000 IE (60 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 60 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 8000 IE (80 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 80 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 8000 IE (80 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 80 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 10000 IE (100 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 100 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 10000 IE (100 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 100 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 12000 IE (120 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 120 mg
Mylan Pharma GmbH
B
FB
G
Inhixa 15000 IE (150 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 150 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan
20
PR
PR
k.A.
Effervescent granulate: Ibuprofenum 600 mg
Mylan Pharma GmbH
B
FB
G
IP
CM
Eotriz 4 mg/5 ml
PR
PR
k.A.
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Future Health Pharma
GmbH
B
FB
G
CM
Xylo-Mepha Dexpanthenol
10 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Mepha Pharma AG
D
FB
G
Co-Valsartan Spirig HC
80/12.5 mg
28
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
Co-Valsartan Spirig HC
80/12.5 mg
98
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
Co-Valsartan Spirig HC
160/12.5 mg
28
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
Co-Valsartan Spirig HC
160/12.5 mg
98
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
Co-Valsartan Spirig HC
160/25 mg
28
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
Co-Valsartan Spirig HC
160/25 mg
98
PR
PR
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
CM
Ibuprofen Mylan 200 mg
30
PR
PR
k.A.
Coated tablets: Ibuprofenum 200 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan 400 mg
20
PR
PR
k.A.
Coated tablets: Ibuprofenum 400 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan 400 mg
50
PR
PR
k.A.
Coated tablets: Ibuprofenum 400 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan 600 mg
20
PR
PR
k.A.
Coated tablets: Ibuprofenum 600 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan 600 mg
100
PR
PR
k.A.
Coated tablets: Ibuprofenum 600 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan retard
20
PR
PR
k.A.
Coated tablets: Ibuprofenum 800 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan retard
50
PR
PR
k.A.
Coated tablets: Ibuprofenum 800 mg
Mylan Pharma GmbH
B
FB
G
CM
Ibuprofen Mylan retard
100
PR
PR
k.A.
Coated tablets: Ibuprofenum 800 mg
Mylan Pharma GmbH
B
FB
G
Valsartan Spirig HC 40 mg
28
PR
PR
k.A.
Coated tablets: Valsartanum 40 mg
Spirig HealthCare AG
B
FB
G
Valsartan Spirig HC 80 mg
28
PR
PR
k.A.
Coated tablets: Valsartanum 80 mg
Spirig HealthCare AG
B
FB
G
Valsartan Spirig HC 80 mg
98
PR
PR
k.A.
Coated tablets: Valsartanum 80 mg
Spirig HealthCare AG
B
FB
G
Valsartan Spirig HC 160 mg
28
PR
PR
k.A.
Coated tablets: Valsartanum 160 mg
Spirig HealthCare AG
B
FB
G
Valsartan Spirig HC 160 mg
98
PR
PR
k.A.
Coated tablets: Valsartanum 160 mg
Spirig HealthCare AG
B
FB
G
CM
Torasemid Mylan 2,5 mg
20
PR
PR
k.A.
Tablets: Torasemidum 2.5 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 2,5 mg
100
PR
PR
k.A.
Tablets: Torasemidum 2.5 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 5 mg
20
PR
PR
k.A.
Tablets: Torasemidum 5 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 5 mg
100
PR
PR
k.A.
Tablets: Torasemidum 5 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 10 mg
20
PR
PR
k.A.
Tablets: Torasemidum 10 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 10 mg
100
PR
PR
k.A.
Tablets: Torasemidum 10 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 200 mg
20
PR
PR
k.A.
Tablets: Torasemidum 200 mg
Mylan Pharma GmbH
B
FB
G
CM
Torasemid Mylan 200 mg
100
PR
PR
k.A.
Tablets: Torasemidum 200 mg
Mylan Pharma GmbH
B
FB
G
IP
Baqsimi 3 mg
PR
PR
k.A.
poudre nasale: Glucagonum 3 mg
Eli Lilly (Suisse) SA
B
FB
G
IP
CM
Propofol Labatec 10mg/ml
50 ml
PR
PR
k.A.
émulsion injectable/pour perfusion: Propofolum 10 mg
Labatec Pharma SA
B
FB
G
IP
CM
Propofol Labatec 10mg/ml
5 x 20 ml
PR
PR
k.A.
émulsion injectable/pour perfusion: Propofolum 10 mg
Labatec Pharma SA
B
FB
G
IP
CM
Propofol Labatec 10mg/ml
5 x 20 ml
PR
PR
k.A.
émulsion injectable/pour perfusion: Propofolum 10 mg
Labatec Pharma SA
B
FB
G
IP
CM
Propofol Labatec 10mg/ml
100 ml
PR
PR
k.A.
émulsion injectable/pour perfusion: Propofolum 10 mg
Labatec Pharma SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2020
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
